医疗保健专业人士对中风后患者药物挑战的看法
Shauna Bell1, Helen Kelly1, Eva Hennessy2
1Department of Speech and Hearing Sciences, University College Cork, Cork, Ireland.
Frontiers in pharmacology
|December 11, 2023
概括
医疗保健专业人员在中风患者护理连续性和出院后药物坚持方面面临着挑战. 改善沟通和资源是获得更好的结果的关键.
科学领域:
- 健康科学 卫生科学 卫生科学
- 临床药房 临床药房
- 康复医学 康复医学 康复医学
背景情况:
- 药物治疗对于中风二次预防至关重要,但在爱尔兰,离院后的坚持目标往往没有得到满足.
- 关于中风护理的社区多学科团队 (MDT) 缺乏定义,导致患者管理不一致.
- 现有的复杂干预措施取得了成功,但在出院后的护理连续性方面仍然存在差距.
研究的目的:
- 探索医疗保健专业人员 (HCP) 关于中风患者护理连续性的知识,态度,信念和挑战.
- 调查这些因素对医院出院后药物坚持的影响.
- 确定中风护理从医院转移到社区环境的改进领域.
主要方法:
- 定性研究采用半结构面试和一个重点小组与医疗保健人员.
- 数据分析使用布劳恩和克拉克的反射主题分析.
- 14名医疗保健专家 (药学,语音语言治疗,职业治疗) 参加了会议.
主要成果:
- 两个主要主题出现了:护理的连续性和药物坚持.
- 护理连续性的子主题包括管理,组织,人际关系和信息方面.
- 影响药物坚持的因素包括与疾病相关的,与药物相关的,全身性,医疗保健专家和患者相关的因素.
结论:
- 需要增加资源,以使社区中风护理与急性护理标准保持一致.
- 改善专业间的沟通,培训,定义的团队结构和质量放电总结是必不可少的.
- 低于最佳的护理连续性有助于药物不服药,突出显示了中风后药物管理的复杂性.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.2K
08:54Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
279
相关概念视频
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:26Psychosis: Goals of Pharmacotherapy
142
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
142
01:24Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
64
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
64
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K